INTRODUCTION
Previous studies 1 -3 have suggested that stressed pregnancies, e.g., preterm premature rupture of membranes (PPROM), are associated with an acceleration of lung maturation. As early as 29 weeks, there is a greater probability in such pregnancies of a lecithin/ sphingomyelin (L/S) ratio of !2 or the presence of phosphatidylglycerol. The objective of our study was to report the pattern of change in L/S in patients with PPROM between 24 and 34 weeks' gestation.
SUBJECTS AND METHODS
The L/S ratio, using transvaginally and transabdominally collected amniotic fluid from nondiabetic patients with PPROM between 24 and 34 weeks' gestation, was determined prospectively on admission and serially every 48 to 96 hours until fetal lung maturity, e.g., L/S!2, was achieved. These patients were seen in the University of Louisville Hospital between August 1992 and November 1995. PPROM was documented by obvious vaginal pooling and/or confirmed by ferning and alkaline pH by nitrazine paper. A culture of the endocervix was used to determine the presence of Neisseria gonorrhea and Chlamydia and a culture from the lower third of the vagina and the anal canal to determine the presence of group B-streptococcus. Each patient was given two intramuscular doses of betamethasone (12 mg) at 12-hour intervals and repeated weekly until delivery or when L/S was !2. All patients were administered prophylactic ampicillin (2 g intravenous piggyback [IVPB] every 6 hours) or if allergic to ampicillin, clindamycin (900 mg IVPB every 8 hours), until group B-streptococcus vaginal cultures returned. Gestational age was determined by best obstetric estimates. All patients were delivered promptly when signs of chorioamnionitis or fetal distress occurred or when L/S was !2. Hyaline membrane disease (HMD) was diagnosed by a chest roentgenogram that noted diffuse
OBJECTIVE:
To report the pattern of change in the lecithin / sphingomyelin ( L / S ) ratio in patients with preterm premature rupture of membranes ( PPROM ) between 24 and 34 weeks' gestation.
STUDY DESIGN:
L / S was determined prospectively using transvaginally and transabdominally collected amniotic fluid from patients with PPROM between 24 and 34 weeks' gestation. Samples were collected prospectively on admission and every 48 to 96 hours until L / S was !2.0. All patients received intramuscular betamethasone weekly.
RESULTS:
Fifty -five patients were included in the study. One hundred twenty -seven samples were collected transvaginally and nine were collected transabdominally. Cox regression analysis showed that a higher initial L / S value and more advanced gestational age were associated with accelerated lung maturation. Among patients at !29 weeks' gestation with an initial L / S of !1.5 and < 2.0 ( n = 17 ) , 15 of 17 ( 88% ) reached L / S!2 at a mean of 3.1 ± 1.7 days ( range 1.0 to 7.0 days ) . With an initial L / S of !1.0 and < 1.5 ( n = 16 ) , 14 of 16 ( 88% ) patients reached L / S!2 at a mean of 4.1 ± 1.9 days ( range 1.7 to 7.0 days ) . With an initial L / S of < 1.0 ( n = 11 ) , 6 of 11 ( 54% ) patients reached L / S!2 at a mean of 5.0 ± 1.6 days ( range 4.7 to 6.8 days ) .
CONCLUSION:
Our data document a dramatic acceleration of fetal lung maturation among patients with PPROM at !29 weeks. Original Article
reticulogranularity and air bronchogram. Analyses of the amniotic fluid were carried out by modification of the methods previously described by Gluck et al. 4 Amniotic fluids were placed in a centrifuge (GCA/Precision Scientific, Chicago, IL) at 1000Âg for 9 minutes as soon as possible after amniocentesis to remove cells and sediment. The percentage of contaminants in the sediment, e.g., blood, mucus, and meconium, was calculated. All specimens were run in duplicate and the analyses were performed at the University of Louisville Perinatal Laboratory. The coefficient of variation for high L/S controls is 10% and 12.5% for low L/S controls. Lipids were extracted by adding an equal volume of absolute methanol (Fisher Scientific, Fair Lawn, NJ) and mixed; 2 volumes of chloroform (Fisher Scientific) were added and mixed again. The resulting emulsion was placed in a À188C freezer (White Westinghouse, Dublin, OH) for 5 minutes and centrifuged for 10 minutes. The chloroform layer was evaporated to dryness with gaseous nitrogen in a heating block set at 60.58C (Diagnositest Heating Block; Dow Diagnostics, Indianapolis, IN). Tubes were placed in the À188C freezer for 5 minutes and cold acetone (Spectranalyzed Acetone; Fisher Scientific) was added to concentrate the surface-active lecithin. The mixture was returned to the freezer for 5 minutes. After centrifuging for 2 minutes, the supernatant was poured off and the acetone precipitate was evaporated to dryness with gaseous nitrogen in the heating block. The lipid sample was dissolved by adding 20 l of chloroform with a Hamilton syringe (Hamilton Co., Reno, NV) and a disposable capillary pipet. That mixture was plated on a heat-activated, thinlayer chromatography plate of silica gel H with 5% ammonium sulphate (Uniplate; Analtech Inc., Newark, DE). The plates used were 20Â20 cm and prescored into four sections. A low and high L/S control made from pooled amniotic fluid, as well as lecithin, sphingomyelin, phosphatidylinositol, and phosphatidylglycerol standard markers (Sigma Chemical Co., St. Louis, MO), were used on each patient's plate. The plate containing the samples, standards and controls was placed back into the 1108C oven for approximately 4 minutes (this aids in the separation of the phospholipids). The plate was removed from the oven, cooled for approximately 3 minutes, and then placed in a thin layer chromatography tank containing chloroform/methanol (Fisher Scientific)/water, 67:26:3.5, v/v/v. The solvent was allowed to migrate about 10 cm from the original spotting. At this time, the plate was removed from the tank and allowed to air dry. The first two sections of the plate were broken apart from the rest and charred on a hot plate set at 2808C for 5 minutes (Corning Glass Works, Corning, NY), and the L/S value was determined by reflectance densitometry (Helena Jr. TLC densitometer/Quick Quant III; Helena Laboratories, Beaumont, TX).
The last two joined sections of the plate (3 and 4) were placed in a 708C oven (Laboratory Oven; Grieve Corp., Round Lake, IL) for 5 minutes. After cooling, they were placed in a second chromatography tank at a 908 angle from the previous run, so that the previous right edge of the plate became the bottom. The developing solvent in the second tank consisted of tetrahydrofuran (Fisher Scientific) / methanol/ammonium hydroxide (Fisher Scientific), 80:57:15.6:8.4, v:v:v:v. After a 10-cm portion of the plate was developed, sections 3 and 4 of the plate were dried, separated, and placed in the oven at 1108C for 5 minutes and transferred to a hot plate for charring for 5 minutes. L/S was read by reflectance densitometry.
Statistical analysis using Spearman's rank correlation coefficient and Cox regression was performed. A p value of 0.05 was considered significant.
RESULTS
Fifty-five patients were included in the study. Thirteen of the 55 patients (24%) received intravenous magnesium sulfate for tocolysis. A total of 136 amniotic fluid samples were collected, 127 transvaginally and 9 transabdominally. The gestational age (median [interquartile range] ) at enrollment was 30.9 weeks [3.8] , whereas the gestational age at delivery was 31.4 weeks [3.5] . The median length of stay at the neonatal intensive care unit was 19 days. 18 Seventy percent (39 of 55) of the patients were white and 30% (16 of 55) were African Americans. Forty-nine percent (27 of 55) of the infants were females. Univariate tests were performed to judge which individual factors were significant for predicting the time to development of lung maturity. The Spearman's correlation coefficient for the initial L/S and the time-to-maturity (r S = À0.5360) was significant (p<0.0005), indicating a shorter time-to-maturity with higher values of the initial L/S. The Spearman's correlation coefficient for gestational age and time-tomaturity (r S = À0.3186) was also significant (p=0.045) and indicative of shorter time-to-maturity with advancing gestational age. The Spearman's correlation coefficient analysis also showed that gestational age and initial L/S are correlated (r S =0.3072, p=0.054), indicating that infants with advanced gestational age are more likely to have a mature L/S. Kaplan-Meier survival analysis was performed using the log-rank test to compare time-to-lung maturity between African Americans and whites. The resulting survival curves were not significantly different (p=0.6347).
Comparison of survival curves between fetal genders also showed no significant differences (p=0.40). Figure 1 shows the two survival curves for fetal gender.
Stepwise Cox regression was performed using the four factors: initial L/S, gestational age, race, and gender, to predict the time needed after birth to attain an L/S of !2. The factor entered first into the regression, hence the most important single predictor, was the initial L/S. The significance of this regression was p<0.0005. A second step entered gestational age and showed a significant improvement in the predictive value of the regression (p=0.0145). The regression coefficients for the initial L/S and gestational age indicate that these factors are associated with accelerated lung maturation. The factors race and fetal gender did not contribute significantly to the prediction of time-to-lung maturity and thus were not entered into the Cox regression equation.
Among patients at or beyond 29 weeks' gestation and depending on the initial L/S, more than 50% of the infants achieved mature L/ S within a mean of 3 to 5 days. This is summarized in Table 1 . There were four (of 33) women whose initial L/S was between 1.0 and 1.9, that did not achieve a mature L/S. All four patients delivered within 1 week. Five (of 11) women whose initial L/S was <1.0 did not achieve a mature L/S. Of these five patients, only one patient received more than one course of betamethasone and delivered 13 days later. At less than 29 weeks, no infants had an L/S of 1.5 or higher on initial sampling. The infrequency of patients with paired samples in this group (n=11) limits comment. However, 5 of 11 patients reached L/S of 2.0 or higher before delivery (the range of values was between 2.5 and 44 days).
HMD occurred in 2 of 40 (5%) patients with L/S of 2.0 or higher. The first infant was a white male whose mother was recruited into the study at 25 weeks. The initial L/S was 1.0. An L/S of 2.0 was achieved after 40 days at a gestation of 31.3 weeks. Subsequent induction of labor delivered to a 2070-g infant, who stayed in the neonatal intensive care unit for 200 days. This infant was on ventilatory support for 100 days and was sent home on oxygen supplementation and a diagnosis of bronchopulmonary dysplasia. A component of pulmonary hypoplasia could not be excluded. The second infant was a white female whose mother was recruited into the study at 24.8 weeks. The initial L/S was 0.5. An L/S of 2.2 was achieved after 11 days (26.4 weeks). At about that time, clinical chorioamnionitis with fetal tachycardia and fetal stress ensued; a classic cesarean section delivered to a 980-g infant. The infant received oxygen and ventilatory support for 12 days and was discharged on day of life 64 with a diagnosis of apnea and bradycardia of prematurity.
DISCUSSION
Our data document a dramatic acceleration of L/S among patients with PPROM at or beyond 29 weeks. This is in agreement with previous observations by Gluck and Kulovich 5 and Richardson et al. 6 however, these patients did not receive antenatal steroids. Additionally, our data indicate that the initial L/S and gestational age are associated with accelerated lung maturation. The more advanced the gestational age and the closer the L/S is to 2.0, the sooner a mature L/S will be observed. The factors race and fetal gender did not contribute significantly to the prediction of time-to-lung maturity. The one shortcoming of our study design is that we did not have a control; however, previous studies 5, 7 have shown that in normal pregnancy with intact membranes, mature L/S (i.e., !2.0) is often observed at about 34 weeks. The median age of our patient with L/S!2.0 at delivery was 31.4 weeks. These previous studies 5, 7 thereby support our observation that L/S rise rapidly in patients with PPROM.
Whether the accelerated L/S maturation is due to the effect of maternal corticosteroid therapy, or to stress secondary to ruptured membranes, is unclear. Corticosteroids may increase the activity of choline phosphotransferase, thereby enhancing the production of fetal surfactant. 8 However, Jobe 9 developed the thesis that the effects of maternal corticosteroid treatment are not primarily on the surfactant system, but rather on other aspects of lung development. In animal models, maternal corticosteroid treatments alter collagen and elastin and increase lung distensibility, 10 increase B-receptor density, 11 increase antioxidant enzymes 12 and decrease the pressure required for lung rupture while increasing the volumes noted at rupture, 13 and decrease the protein leak from the vascular space to the alveoli, but did not alter surfactant pools or compliances. 14 Controversy also exist as to whether amniotic fluid phospholipid 15, 16 concluded that there was no difference in L/S after dexamethasone therapy. Spellacy et al. 17 reported a greater rate of rise in L/S after dexamethasone injections than in uninjected control pregnancies. Subsequently, 14 other investigations on this issue as reviewed by Morrisson et al. 18 revealed that about half found an increase in L/S after treatment with various steroid hormones and the remainder demonstrated no change. Farrell et al. 19 analyzed their data from a double-blind randomized trial that involved pregnant patients at five perinatal centers. They found nearly identical L/S values initially and no statistically significant difference in the posttreatment means (within 3 to 9 days apart) when 25 steroidtreated pregnancies were compared to 20 control pregnancies. Each of these reports evaluated patients with intact membranes. Berkowitz et al. 20 suggested that ruptured membranes for more than 16 hours serve as a sufficient stressful stimulus for infants of 31 weeks or more. Spinnato et al. 21 in their report on a largely indigent black population, found that mature test of fetal pulmonary status was not uncommon at 32 weeks and suggested that when pulmonary maturity is present, the risk of conservative management may exceed the potential for benefit. From the same institution, Mercer et al. 22 randomized 93 women with PPROM between 32 and 36 weeks' gestation to induction of labor or expectant management after determining fetal lung maturity. They concluded that immediate induction of labor reduces the duration of hospitalization and infection in both mothers and neonates. Bauer et al. 23 demonstrated a correlation between fetal blood cortisol and the duration of rupture of membranes. They suggested that the cortisol increase might have accelerated pulmonary maturation and therefore decreased the incidence of respiratory distress syndrome.
Overall, the strikingly high percentage of patients with PPROM at and beyond 29 weeks' gestation who achieved a mature L/S within a relatively short period of time may explain the reported lack of benefit with regards to neonatal mortality and morbidity of prolonged latency in such patients. 21, 22, 24 If one chooses to direct the management of patient with PPROM based on L/S as outlined by Morrisson et al. 18 and Farrell et al., 19 it is important to obtain L/S frequently. From the data, it would appear that a minimum frequency of every 3 to 4 days would be necessary. When the gestational age is advanced and L/S is near 2.0, one may be rewarded with a mature L/S within 24 to 48 hours.
Previous published data 21, 25 indicated that using vaginal pool amniotic fluid to determine fetal pulmonary maturity is as reliable as using an amniotic fluid specimen collected by the more invasive method of amniocentesis. The positive predictive value in detecting the absence of HMB was 96%. 25 This makes the task of serial L/S determination easy, noninvasive, and informative. Our study demonstrates that serial transvaginal collection of amniotic fluid for fetal lung maturity is feasible in patients with PPROM. Stedman et al. 26 reported that daily aspiration of amniotic fluid pooled in the vagina for fetal pulmonary lung profile has had a successful collection rate of 80%. 26 The influence of steroids as an adjunct in enhancing the likelihood of mature L/S in patients with PPROM was not tested by our study design. A prospective randomized control trial is necessary to answer this question. The change of L/S observed in this study may not be generalized to the other fetal lung maturity test. Observational study with close follow-up of the trend of other fetal lung maturity testing is necessary.
